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Abstract 
Objective: The objective of the study is to predict the odds of death in participants with 
bronchiectasis and to determine if ever smokers have increased odds of death when 
compared to never smokers.  
Methods: Data for the study was used from the Bronchiectasis Research. Pearson chi 
square test is used to compare never smokers to ever smokers for age, gender, and 
participants enrolled status. Logistic regression is used to predict the odds of death for 
smoking status, age, gender, or CT scan findings. CT scan findings for this study are 
dilated airways, airways that are thickening, tree-in-bud infiltrates or mucoid impaction.  
Result: The study determined that 60% of the bronchiectasis participants in the study 
are between 60 and 79 years of age, 79% of the populations are females, and 60% 
have never smoked. Ninety percent of the populations are currently enrolled as active, 
5% have been lost to follow up and 5% are deceased. The multivariate logistic 
regression model for predicting the odds of death resulted in an odds ratio of 2.67 for 
males, 1.06 for age and 1.75 for ever smokers.  
Conclusions: There is a statistically significant difference in the data sets when 
comparing never smokers to ever smokers for gender, age, and participant status. 
Gender, age, and smoking status are predictors of the odds for death. Males are 2.67 
times more likely to die than females. Smokers are 1.75 times more likely to die than 
non-smokers. CT scan findings are not predictors of the odds for death.  
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 I. Introduction 
Bronchiectasis is a growing concern in the US. The prevalence of non-cystic fibrosis 
bronchiectasis was estimated to be 2.6% in hospitalized patients by Goeminne et al. 
(2012). Bronchiectasis is a cause of morbidity in adults and can be diagnosed through 
high-resolution chest computed tomography (HRCT) scans in addition to clinical 
findings. In order for a patient to be diagnosed with Bronchiectasis the HRCT must 
show the internal diameter of the bronchus to be larger than the accompanying vessels 
or the bronchus must fail to taper in the periphery of the chest. Figure 1 illustrates 
bronchiectasis as it appears in CT scans. Bronchiectasis prevalence continues to grow 
as does the ability to detect bronchiectasis. An increase in the utilization of CT scans 
can constitute some of the reasons behind the increasing prevalence. It is also 
important to understand the factors that contribute to mortality (McShane et al., 2013).  
There are several various causes of bronchiectasis ranging from post infectious to 
post inflammatory pneumonitis to congenital bronchial abnormalities. Viral or fungal 
infections are included under post infectious. Swyer-James syndrome is a viral infection. 
Allergic bronchopulmonary aspergillosis (ABPA) is a fungal infection and reaction to that 
infection. Maounier-Kuhn’s syndrome and Williams-Cambell syndrome are types of 
congenital bronchial abnormalities. Aspiration and inhalation of toxic gases are 
categorized as post inflammatory pneumonitis, non-tuberculosis mycobacterium (NTM) 
AIDS, asthma, cystic fibrosis, and rheumatoid arthritis are additional causes of 
bronchiectasis (McGuinness & Naidich, 2002).  
This study uses data from the Bronchiectasis Research Registry where patients 
enroll in 13 academic medical centers across the United States. The study focuses on 
 patients that are 20 years of age or older with documented smoking status that are self-
enrolled in the Bronchiectasis Research Registry. Patients who have ever been 
smokers with Bronchiectasis may have increased odds of death.  
The Capstone will include a Literature Review chapter of existing literature focused 
on prior Bronchiectasis research, a Methodology chapter with a detailed explanation of 
how the study was conducted, a Results chapter with discussion around the study 
findings, and a Conclusion chapter with a summary of the study and public health 
implications. 
 
II. Literature Review 
This section will provide background around bronchiectasis, which includes 
prevalence rates and the odds of death. The literature section will also spend some time 
reviewing the effects of smoking. The last part of the chapter will discuss CT scan 
results as they relate to bronchiectasis.  
One study found that bronchiectasis diagnoses increased by 8.7% each year by 
studying claims data from 2000 to 2007 among Medicare recipients, which could be 
attributed to a true increase in the condition or an increase in diagnosing the condition in 
previously undiagnosed recipients (due to  an increase in the number of CT scans over 
that period). Bronchiectasis incidence was 370 cases per 100,000 person-years and 
higher among women and Asians (Seitz et al., 2012).  
 Loebinger et al. (2009) estimated the expected death rate of a 52 yr old 
diagnosed with bronchiectasis at 14.7% for males and 8.9% for females over 13 years 
of follow up. The overall survival rates were determined to be 91% after 4 years, 83.5% 
after 8.8 years and 68.1% after 12.3 years. Goeminne et al. (2012) saw an increased 
death rate with bronchiectasis patients diagnosed with COPD (26%). Active smokers 
suffering from bronchiectasis are 1.98 times more likely to die when compared to non-
smokers and former smokers are 1.87 times more likely to die. (Goeminne et al., 2012) 
 Cigarette smoking is the leading cause of preventable death in the United States, 
with approximately 480,000 premature deaths each year (American Cancer Society, 
2016; Jamal, 2015). Smoking is attributed to almost 1 in 5 deaths in the United States. 
Approximately 87% of lung cancer deaths in men are caused by smoking and 70% of 
those in women. Lung cancer is the largest cause of cancer related deaths in men and 
women (American Cancer Society, 2016). Continuous smokers have about a 25% risk 
of developing COPD (Lokke et al., 2006). Patients with COPD have an increased risk of 
developing lung cancer (Purdue et al., 2007). Smoking has a greater damaging effect 
on the lungs of patients with COPD then those without COPD (Huang et al., 2015). Lee 
et al. (2015) evaluated other risk factors other than smoking that contribute to chronic 
obstructive pulmonary disease (COPD). They found that never smokers with 
bronchiectasis were 6 times more likely to have COPD.  
CT Scans are the primary means of determining the extent and severity of 
bronchiectasis. Wall thickening of the bronchial tube is an indirect sign of bronchiectasis 
while dilated bronchi are commonly thickened; dilated bronchi can also exist without 
being thickened (Lynch, 1993). A thick wall cavity CT scan is shown in Figure 2A. 
 Bronchiectasis could be difficult to diagnosis if arterial dilation conceals a dilated 
bronchus. Cylindrical bronchiectasis is recognized from a CT scan when a dilated 
bronchus is parallel to the plane of the CT. The uniform dilated airways will resemble 
tram tracks or parallel lines as seen in Figure 1A. Ring structures are present when a 
dilated bronchus is perpendicular to the plane of the CT section. The internal diameter 
of the dilated bronchus will be larger than the accompanying pulmonary artery branch 
(McGuinness & Naidich, 2002). 
   Mucoid impaction is the progressive accumulation of mucus and inflammatory 
products in the bronchial lumen. Mucoid impaction leads to progressive dilation and 
bronchiectasis (Subash et al., 2015).  Mucoid impaction typically encompasses the 
peripheral airways of patients with post-inflammatory bronchiectasis (McGuinness & 
Naidich, 2002). A CT scan that illustrates mucus impaction is shown in Figure 2C. One 
study focused on allergic bronchopulmonary aspergillosis patients found that 74 of 100 
patients had central bronchiectasis. Of the 74 patients 47 showed evidence of mucoid 
impaction. Mucoid impaction was more common in men than women, 30 to 17 
respectively (Subash et al., 2015).  
The small airways or terminal bronchioles are visible on CT images with tree-in-bud 
pattern. Otherwise, they are too small to appear on the CT images in their normal state 
(Walker et al., 2014).  Tree-in-bud can be a result of the following 1) central 
bronchiectasis with peripheral air trapping, 2) peripheral bronchiectasis and bronchiolar 
luminal impaction, or 3) extensive airway and lung parenchyma disease. Each case will 
look differently on a HRCT (Collins, Blankenbaker, & Stern, 1998). One will look like an 
overly pruned tree, two will show up as a tree budding in the springtime, and three will 
 resemble a full summer foliage tree. The tree-in-bud pattern is most commonly seen in 
infectious bronchiolitis (Ng et al., 2009). Figure 2B is an example of tree-in-bud pattern 
as it appears in a CT scan.  
 
III. Methodology 
This study uses de-identified data from the Bronchiectasis Research Registry. The 
goal of the Registry is to create a database that can be used for research and clinical 
trials by aggregating patients across multiple clinics that treat bronchiectasis 
(Bronchiectasis and NTM Research Registry, 2016). Patients have the option to fully 
consent to participate in the research registry, partially consent, and withdraw at any 
time (or refuse to enroll). After consent, there is an initial enrollment form that is 
completed by project staff. The enrollment packet consists of a consent form, 
demographic form, participant tracking form, clinical procedures form, medical history 
form, microbiology form, therapies form, imaging form, respiratory symptoms, 
mycobacterial culture, NTM history, NTM Treatment and drug history and NTM 
therapies. The registry also tracks annual follow up with a separate form.   
The data analysis will include descriptions around the comparative demographic 
tables, comparative tables for CT scan results and details on several summary tables of 
the logistic regression results. Pearson Chi-Squared is used to determine if there is a 
statistically significant difference between ever smokers and never smokers in when 
comparing demographic details about participants. The study specifically compares 
 data from ever smokers to never smokers in order to determine the odds of death 
associated with patients diagnosed with bronchiectasis. 
 Several logistic regression models were created to illustrate the covariates that 
increase the odds of mortality in patients diagnosed with bronchiectasis. The covariates 
used in the logistic regression models were; age, gender, smoking status, history of 
COPD, and CT scan results. CT scan results included dilated airways, thickened 
airways, tree-in-bud infiltrates, and mucoid impaction.   
   
IV. Results 
Table 1 illustrates the frequency of patient demographics of the population both 
overall and stratified by smoking status. The comparative analysis focuses on age, 
gender, and participant status shown in Table 1. Over 50% of the bronchiectasis 
population for this study falls within 60 and 79 years of age. Over 75% of the population 
is female.  
Never smokers make up 60% of the bronchiectasis population used for this study. 
Seventy- eight percent of the participants are women (Table 1). Sixty-two percent of 
women have never smoked that have bronchiectasis compared to 52% of men that 
have never smoked. The majority of the population, 90.1%, is still active whereas 5.4% 
are lost to follow up, and 4.5% are deceased. Ever smokers had more deaths when 
compared to never smokers, 6.8% and 3.0% respectively.  
 The data in Table 2 compares the distribution for never and ever smokers looking at 
a history of COPD or several CT scan results. Nineteen percent of the population had a 
history of COPD and of the 19%, 62% were ever smokers. Seventy-nine percent of the 
population had dilated airways and over 50% of the population had airways that are 
thickening or tree-in-bud infiltrates. Only 39% of the population had mucoid impaction; 
however they had the highest percentage of never smokers at 63%. Between 35% and 
45% of the participants with bronchiectasis that had a positive CT scan were ever 
smokers. Figure 3 illustrates the different percentages for total population, ever 
smokers, and never smokers as they relate to patients with a history of COPD and CT 
scan findings. Pearson Chi-Square had a p-value of < 0.001 for age and gender when 
comparing ever smokers to never smokers in Table 1.  Table 2 had a p-value of 0.001 
when comparing ever smokers to never smokers for participants that had a history of 
COPD. Airways are thickening returned a p-value of 0.024 and a 0.020 p-value for 
mucoid impaction. Dilated airways and tree-in-bud infiltrates retuned greater than 0.005 
p-values for Pearson Chi-Square. 
Next we will look at logistic regression models that predict death for participants with 
bronchiectasis. Table 3 is predicting death using gender, age, and smoking status as 
covariates. Each covariant is statistically significant with all covariates having a p-value 
0.016 or less for the univariate or multivariate models. The multivariate model findings 
are males have 2.7 times more likely to die with bronchiectasis than females and ever 
smokers are 1.7 times more likely to die with bronchiectasis than never smokers. Age is 
a continuous variable; therefore there is a 1.06 times increased chance that a 
participant will die for every one year the participant gets older in the multivariate model. 
 The odd ratio for gender and age are comparable for the univariate models and 
multivariate model. The univariate model for smoking status has ever smokers being 2.3 
times more likely to die than compared to the multivariate model that had ever smokers 
1.7 times more likely to die.  
Table 4 includes the results for a logistic regression model with additional covariates 
for patients that have a history of COPD and CT scan results. The additional covariates 
are dilated airways, airways that are thickened, tree-in-bud infiltrates, and mucoid 
impaction. The odds ratio for gender, age, and smoking status slightly changed. 
Smoking status p-value dropped from 0.000 to 0.050 for the multivariate model. History 
of COPD p-value also dropped from 0.000 to 0.056 and patients with a history of 
smoking are 1.62 times more likely to die with bronchiectasis on the multivariate model. 
The covariates for CT scans are not statistically significant with the univariate models or 
multivariate model. The p-values are ranging from 0.263 to 0.604 on the univariate 
models.  
 
V. Conclusion 
This analysis supports earlier findings that men have a higher death rate than 
women, since this study determined that men are 2.7 times more likely to die than 
women (Loebinger et al., 2009). This data also supports women having a higher 
prevalence than men with 79% of the population in this study being women compared to 
21% men (Seitz et al., 2012). There may be some participation bias as females tend to 
seek medical attention more frequently during illness; however that would not account 
 for such a large difference between males and females. Age, gender and participants 
status were statistically significant using Pearson Chi-Square comparing ever smokers 
to never smokers.  
When considering age distribution associated to smoking status only 4.5% of the 
smoking population is less than 50 years old. This could be due to the known risks 
associated with smoking could have impacted more people to never start smoking.  The 
difference in population distribution by age range when comparing patients with a 
history of smoking to never smokers could be due to the those that are between 50 to 
69 years of age are having health hazards associate with Bronchiectasis or other 
conditions that have influenced there decision to quit smoking.   
Next topic of discussion is around mortality relating to smoking and COPD. Ever 
smokers have an increased risk of 1.75 times more likely to die when compared to 
never smokers was similar to Goeminne et al. (2012). Goeminne et al. (2012) 
concluded active smokers suffering from bronchiectasis are 1.98 times more likely to die 
when compared to non-smokers and former smokers are 1.87 times more likely to die. 
Smoking is a cause of lung cancer; therefore it makes sense that a larger portion of 
those with a history of smoking are deceased compared to never smokers being 
deceased. Due to smoking being the leading cause of preventable death, it is not 
surprising that a history of COPD would be statistically significant covariate when 
comparing Table 4 to Table 3 multivariate p-values (American Cancer Society, 2016). A 
history of COPD is a cofounder to ever smoking status, which is reflected in the 
decrease of the p-value for ever smokes from Table 3 to Table 4.  
 The Bronchiectasis Research Registry had some data limitation. There were few 
deceased patients. The data was pared down to focus on adults only and patients with 
a smoking status. Patients with an unknown smoking status were removed from the 
data set and data was removed for those under the age of 20 years old. 
In conclusion, Table 3 illustrates the covariates that are statistically significant to 
predict death in participants that have bronchiectasis. The covariates are gender, age, 
and smoking status. It is not surprising that a participant is 1.06 times more likely to die 
with every year they get older in the multivariate model. The odds of dying will increase 
with age.  It is also known that smoking is the leading cause of preventable death 
(American Cancer Society, 2016). CT scan findings are not a predictor of death in 
participants that are diagnosed with bronchiectasis.   
Bronchiectasis continues to be a concern in the US as the prevalence is 
increasing. The Bronchiectasis Research Registry is assessable for research purposes 
similar to this study. A growing interest in bronchiectasis will lead to additional studies 
resulting in new findings regarding bronchiectasis. 
 
 
 
 
 
 
 APPENDIX  
A   B  
C  
Image 1. Bronchiectasis; A is cylindrical bronchiectasis is identify by the solid arrows 
and plane section bronchiectasis appears as ‘‘tram tracks’’ indicated by the open 
arrows. The solid arrow is a cross section of dilated bronchi that appears as a “signet 
ring”. The CT scan also reveals thin and thick walls of these bronchi (McGuinness& 
Naidich, 2002). B is bronchiectasis shown by the solid arrow and arrow head (Collins et 
al., 1998). C has arrows point to bronchiectasis (McGuinness& Naidich, 2002). 
 
 A    B  
C  
Image 2. CT scan finding in bronchiectasis patients. A is a CT scan with thick-walled 
cavities in right lower lobe. B is a CT scan shows tree-in-bud pattern in the right lower 
lobe (Collins et al., 1998). C has arrows and asterisk representing mucus impaction 
(McGuinness& Naidich, 2002). 
 
 
 
  
 
Total Population Never Smoker Ever Smoker  P - Value 
 N Percent N Percent N Percent  
 1873  1120 59.8% 753 40.2%  
        
Age       0.000 
Mean 64.3  62.0  67.8   
20-29 50 2.7% 47 4.2% 3 0.4%  
30-39 76 4.1% 69 6.2% 7 0.9%  
40-49 120 6.4% 96 8.6% 24 3.2%  
50-59 315 16.8% 190 17.0% 125 16.6%  
60-69 581 31.0% 328 29.3% 253 33.6%  
70-79 537 28.7% 287 25.6% 250 33.2%  
80 < 194 10.4% 103 9.2% 91 12.1%  
Total 1873  1120  753   
        
Gender       0.000 
  Male 398 21.2% 205 18.3% 193 25.6%  
  Female 1475 78.8% 915 81.7% 550 73.0%  
Total 1873  1120  753   
        
Status       0.001 
Active 1687 90.1% 1019 91.0% 668 88.7%  
Lost to Follow-
Up 
101 5.4% 67 6.0% 34 4.5%  
Deceased 85 4.5% 34 3.0% 51 6.8%  
 1873  1120  753   
Table 1. Distribution of demographic identifiers stratified by smoking status 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Total Population Never Smoker  Ever Smoker P - value 
 N Percent N Percent N Percent  
 1873  1120 59.8% 753 40.2%  
        
History of COPD 359 19.2% 138 12.3% 221 29.3% 0.000 
Dilated airways 1473 78.6% 867 77.4% 606 80.4% 0.112 
Airways are 
Thickening  
1078 57.6% 621 55.4% 457 60.7% 0.024 
Tree-in-bud 
infiltrates 
953 50.9% 581 51.9% 372 49.4% 0.294 
Mucoid 
impaction 
724 38.7% 457 40.8% 267 35.5% 0.020 
Table 2. Distribution of identifiers stratified by smoking status  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 3. Distribution of ever and never smokers associated with history of COPD and 
CT scan findings 
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Total Percent
Never Smokers Percent
Ever Smokers Percent
  Univariate Models Predicting Death Multivariate Model Predicting Death 
Factor Odds Ratio 95% CI P-value Odds Ratio 95% CI P-value 
Gender       
   Female Reference   Reference   
   Male 2.586 1.651 – 4.052 0.000 2.672 1.686 – 4.236 0.000 
Age in 
years 
      
 1.060 1.038 – 1.083 0.000 1.060 1.037 – 1.084 0.000 
Smoking 
Status 
      
   Never Reference   Reference   
   Ever 2.322 1.489 – 3.621 0.000 1.748 1.109 – 2.754 0.016 
Table 3. Odds of death in males, one year increase in age, and never smokers with 
bronchiectasis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Univariate Models Predicting Death Multivariate Model Predicting Death 
Factor Odds Ratio 95% CI P-value Odds Ratio 95% CI P-value 
Gender       
   Female Reference   Reference   
   Male 2.586 1.651 – 4.052 0.000 2.448 1.517 – 3.950 0.000 
Age in 
years 
      
 1.060 1.038 – 1.083 0.000 1.058 1.035 – 1.082 0.000 
Smoking 
Status 
      
   Never Reference   Reference   
   Ever 2.322 1.489 – 3.621 0.000 1.599 1.000 – 2.557 0.050 
Pt dx with 
COPD 
      
   No Reference    Reference   
   Yes 2.534 1.604 – 4.005 0.000 1.617 0.988 – 2.646 0.056 
Dilated 
Airways 
      
   No Reference    Reference    
   Yes 1.158 0.664 – 2.019 0.604 0.955 0.501 – 1.820 0.889 
Airways are 
Thickened 
      
   No Reference   Reference   
   Yes 1.294 0.824 – 2.033 0.263 1.062 0.621 – 1.818 0.826 
Tree-in-bud 
Infiltrates 
      
   No Reference   Reference   
   Yes 0.889 0.575 – 1.374 0.596 0.899 0.543 – 1.489 0.679 
Mucoid 
Impaction 
      
   No Reference   Reference   
   Yes 1.231 0.793 – 1.909 0.355 1.289 0.777 – 2.138 0.326 
Table 4. Odds of death in males, one year increase in age, never smokers patients with 
a history of COPD and findings on CT scans in participants with bronchiectasis  
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